These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36622134)

  • 1. Juvenile dermatomyositis in a Duchenne muscular dystrophy carrier.
    Hao S; Yue D; Zhu W; Huang W
    Clin Exp Rheumatol; 2023 Mar; 41(2):398. PubMed ID: 36622134
    [No Abstract]   [Full Text] [Related]  

  • 2. Dermatomyositis developing in a Duchenne muscular dystrophy carrier.
    Bennett AN; Sangle SR; Hughes GR; D'Cruz DP
    Rheumatology (Oxford); 2004 May; 43(5):668-9. PubMed ID: 15103031
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy.
    Monici MC; Aguennouz M; Mazzeo A; Messina C; Vita G
    Neurology; 2003 Mar; 60(6):993-7. PubMed ID: 12654966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experiences of Women Who Have Had Carrier Testing for Duchenne Muscular Dystrophy and Becker Muscular Dystrophy During Adolescence.
    Fraser HG; Redmond RZ; Scotcher DF
    J Genet Couns; 2018 Dec; 27(6):1349-1359. PubMed ID: 29974322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strength training and aerobic exercise training for muscle disease.
    Voet NB; van der Kooi EL; van Engelen BG; Geurts AC
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD003907. PubMed ID: 31808555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to american academy of pediatrics recommendations for cardiac care among female carriers of duchenne and becker muscular dystrophy.
    Bobo JK; Kenneson A; Kolor K; Brown MA
    Pediatrics; 2009 Mar; 123(3):e471-5. PubMed ID: 19254982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic analysis and prenatal diagnosis of Duchenne or Becker muscular dystrophy].
    Zhao W; Jiang N; Li S; Li JS; Miao Y; Liang SY; Yu DY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Apr; 54(4):226-231. PubMed ID: 31006187
    [No Abstract]   [Full Text] [Related]  

  • 8. Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic Features.
    Moneta GM; Pires Marafon D; Marasco E; Rosina S; Verardo M; Fiorillo C; Minetti C; Bracci-Laudiero L; Ravelli A; De Benedetti F; Nicolai R
    Arthritis Rheumatol; 2019 Jun; 71(6):1011-1021. PubMed ID: 30552836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duchenne muscular dystrophy: issues in expanding newborn screening.
    Kemper AR; Wake MA
    Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underlying diseases in sporadic presentation of high creatine kinase levels in girls.
    Lee T; Tokunaga S; Taniguchi N; Misaki M; Shimomura H; Nishino I; Itoh K; Takeshima Y
    Clin Chim Acta; 2021 Aug; 519():198-203. PubMed ID: 33965408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DMD and West syndrome.
    Cardas R; Iliescu C; Butoianu N; Seferian A; Gataullina S; Gargaun E; Nectoux J; Bienvenu T; Craiu D; Gidaro T; Servais L
    Neuromuscul Disord; 2017 Oct; 27(10):911-913. PubMed ID: 28802771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Duchenne muscular dystrophy with autism spectrum disorder.
    Wu JY; Kuban KC; Allred E; Shapiro F; Darras BT
    J Child Neurol; 2005 Oct; 20(10):790-5. PubMed ID: 16417872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge of carrier status and barriers to testing among mothers of sons with Duchenne or Becker muscular dystrophy.
    Bogue L; Peay H; Martin A; Lucas A; Ramchandren S
    Neuromuscul Disord; 2016 Dec; 26(12):860-864. PubMed ID: 27863875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends with corticosteroid use in males with Duchenne muscular dystrophy born 1982-2001.
    Fox DJ; Kumar A; West NA; DiRienzo AG; James KA; Oleszek J;
    J Child Neurol; 2015 Jan; 30(1):21-6. PubMed ID: 24682290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential cross-talk between muscle and tendon in Duchenne muscular dystrophy.
    Yuan C; Arora A; Garofalo AM; Grange RW
    Connect Tissue Res; 2021 Jan; 62(1):40-52. PubMed ID: 32867551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis.
    Tezak Z; Hoffman EP; Lutz JL; Fedczyna TO; Stephan D; Bremer EG; Krasnoselska-Riz I; Kumar A; Pachman LM
    J Immunol; 2002 Apr; 168(8):4154-63. PubMed ID: 11937576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies.
    Becker N; Moore SA; Jones KA
    Acta Neuropathol Commun; 2022 Feb; 10(1):17. PubMed ID: 35135626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment and genetic counseling in families with Duchenne muscular dystrophy.
    Grimm T; Kress W; Meng G; Müller CR
    Acta Myol; 2012 Dec; 31(3):179-83. PubMed ID: 23620649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of osmolyte pathways in inflammatory myopathy and Duchenne muscular dystrophy points to osmoregulation as a contributing pathogenic mechanism.
    De Paepe B; Martin JJ; Herbelet S; Jimenez-Mallebrera C; Iglesias E; Jou C; Weis J; De Bleecker JL
    Lab Invest; 2016 Aug; 96(8):872-84. PubMed ID: 27322952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical Activity in Boys With Duchenne Muscular Dystrophy Is Lower and Less Demanding Compared to Healthy Boys.
    Heutinck L; Kampen NV; Jansen M; Groot IJ
    J Child Neurol; 2017 Apr; 32(5):450-457. PubMed ID: 28112012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.